The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.

Ismail G, Zeineddine M, Al-Roughani R, Ahmed SF, Al-Mahdawi A, Khoury S, El-Ayoubi N, Inshasi J, Al-Khabouri J, Al-Asmi A, Gouider R, Aljarallah S, Alkhawajah N, Al Malik Y, Abulaban A, Makkawi S, Khojah O, El-Hajj T, Massouh J, AlSalamat H, Al-Hajje A, Salameh P, Boumediene F, Yamout B

Open source

DOI: 10.1016/j.neurot.2026.e00861
Published: 2026 Mar
Container: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2026.e00861,
  title = {The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.},
  author = {Ismail G and Zeineddine M and Al-Roughani R and Ahmed SF and Al-Mahdawi A and Khoury S and El-Ayoubi N and Inshasi J and Al-Khabouri J and Al-Asmi A and Gouider R and Aljarallah S and Alkhawajah N and Al Malik Y and Abulaban A and Makkawi S and Khojah O and El-Hajj T and Massouh J and AlSalamat H and Al-Hajje A and Salameh P and Boumediene F and Yamout B},
  year = {2026},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  doi = {10.1016/j.neurot.2026.e00861},
  url = {https://doi.org/10.1016/j.neurot.2026.e00861}
}

RIS

TY  - JOUR
TI  - The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.
AU  - Ismail G
AU  - Zeineddine M
AU  - Al-Roughani R
AU  - Ahmed SF
AU  - Al-Mahdawi A
AU  - Khoury S
AU  - El-Ayoubi N
AU  - Inshasi J
AU  - Al-Khabouri J
AU  - Al-Asmi A
AU  - Gouider R
AU  - Aljarallah S
AU  - Alkhawajah N
AU  - Al Malik Y
AU  - Abulaban A
AU  - Makkawi S
AU  - Khojah O
AU  - El-Hajj T
AU  - Massouh J
AU  - AlSalamat H
AU  - Al-Hajje A
AU  - Salameh P
AU  - Boumediene F
AU  - Yamout B
PY  - 2026
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
DO  - 10.1016/j.neurot.2026.e00861
UR  - https://doi.org/10.1016/j.neurot.2026.e00861
ER  -

APA

G, I., M, Z., R, A., SF, A., A, A., S, K., N, E., J, I., J, A., A, A., R, G., S, A., N, A., Y, A. M., A, A., S, M., O, K., T, E., J, M., H, A., A, A., P, S., F, B., & B, Y. (2026). The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2026.e00861

Source records

pubmed · retrieved 2026-09-26T11:12:16.669Z